mass cytometry Standard BioTools Q1 Revenues Fall 19 Percent In Q1 the company formerly known as Fluidigm completed a strategic evaluation process and closed a $250 million capital infusion from Casdin Capital and Viking Global Investors. Single-Cell Proteomic Analysis Points to Role of Rare Cell Populations in Localized Prostate Cancer Some rare cell populations identified have been linked to aggressive or metastatic disease. New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia Premium At AACR, researchers described how pediatric ALL patients who don't respond to anti-CD19 CAR T-cell therapy have cancers with a unique, stem cell-like epigenome. Fluidigm Appeal in IonPath Patent Infringement Battle Voluntarily Dismissed The verdict seemingly closes a lawsuit filed by Fluidigm against IonPath in 2019 for allegedly infringing patents covering Fluidigm's mass cytometry technology. Fluidigm Q2 Revenues Grow 19 Percent The firm noted that its base product and service revenue (excluding COVID-19 testing) increased 33 percent year over year to $26.9 million. Aug 5, 2021 Fluidigm Inks Comarketing Pacts With Ultivue, ImaBiotech May 5, 2021 Maternal Blood Proteomic, Metabolomic Changes Could Predict Onset of Labor Feb 11, 2021 Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID Premium Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Feb 10, 2021 ImmunoScape, Johns Hopkins Team Profiles T Cell Response in COVID-19 Patients Premium Nov 5, 2020 Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Aug 10, 2020 T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma Aug 4, 2020 Fluidigm, De Novo Software Ink Distribution Deal Jul 14, 2020 Newly Proposed B Cell Atlas Identifies 12 Unique Subsets May 7, 2020 Fluidigm Q1 Revenues Fall 8 Percent Apr 30, 2020 Washington University, BostonGene Expand Kidney Cancer Research Collaboration Feb 26, 2020 Fluidigm Acquires Cytometry Sample Prep Firm InstruNor for $7.2M Feb 10, 2020 Fluidigm Reports Flat Q4 Revenues Jan 24, 2020 Federal Court Whittles Down Fluidigm Lawsuit Against IonPath Jan 21, 2020 Imaging Mass Cytometry Uncovers Novel Breast Cancer Subgroups Associated With Outcomes Jan 14, 2020 Fluidigm Anticipates Flat Q4 Revenues Nov 5, 2019 Fluidigm Q3 Revenues Fall 9 Percent on Mass Cytometry Weakness Sep 10, 2019 Fluidigm Sues IonPath for Patent Infringement, Interference Aug 1, 2019 Fluidigm Q2 Revenues Grow 7 Percent; Stock Tumbles on Microfluidics Weakness, Soft Guidance May 3, 2019 Fluidigm Q1 Revenues Soar 19 Percent Load More Breaking News Single-Nucleus Chromatin Accessibility Profiling in Coronary Artery Disease Points to Mechanisms ALL Genomes Marked by High DNA Methylation Levels Cepheid Gets CE Mark for Updated Rapid COVID MDx Test Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE CellCarta Acquires Rights to Targeted Protein Assays from Fred Hutch Spinout Precision Assays Genetic Analysis, Omnigene Medical Technologies Ink Distribution, Tech Transfer Deal The Scan Monkeypox Case Found in US The New York Times says that a case of monkeypox has now been reported in the US. Effects on Fetal Screening Wired writes that changes to US abortion laws could affect screening for fatal congenital conditions. 'Pharma Bro' Out of Prison The Wall Street Journal reports that Martin Shkreli has been released from prison to a halfway house. Nature Papers Present Cultivate Oat Genome, Benchmarking of Spatial and Single-Cell Transcriptomic Integration Methods In Nature this week: reference genome of the cultivated oat, and more.